Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second FDA clearance of a QIAstat-Dx panel in 2025 ...

Detailed price information for Allogene Therapeutics Inc (ALLO-Q) from The Globe and Mail including charting and trades.

Plug Power faces high risks despite a DOE loan guarantee, with funding gaps, policy shifts, and delays looming. Click here to ...

Operator Good day, and welcome to the FedEx third quarter fiscal 2025 earnings call. All participants are in listen-only mode ...

Target Corporation TGT released its fourth-quarter fiscal 2024 results last Tuesday before the opening bell, sparking fresh debate among investors regarding the stock's future trajectory.

Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the U.S., the release ...

He received his M.A. in journalism from The New School and his B.A. in history and political science from McGill University. Artur Widak / NurPhoto / Getty Images Nvidia (NVDA) stock rose nearly 4 ...

Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...

A MAJOR DIY retailer is set to close 10 branches within days as giant clearance sales are launched ... Among them is B&Q, which has agreed to buy eight of the chain’s branches that were ...

Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

In a meeting last year of the SEC’s Investor Advisory Committee, the Committee heard from a panel regarding the continued viability—or rather, ...